Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Advances in targeted therapy for melanoma
Philip Friedlander
, F. Stephen Hodi
Research output
:
Contribution to journal
›
Review article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in targeted therapy for melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Melanoma
100%
Targeted Therapy
100%
Malignancy
33%
Mitogen-activated Protein Kinase
33%
Metastatic Melanoma
16%
Signal Transduction Pathway
16%
Oncogene
16%
Poor Prognosis
16%
Clinical Investigation
16%
Aberrations
16%
Optimal Treatment
16%
Molecular Targeted Therapy
16%
Molecular Abnormalities
16%
Advanced Melanoma
16%
Targeting Strategies
16%
Overall Survival Benefit
16%
Acral
16%
Medicine and Dentistry
Targeted Therapy
100%
Melanoma
100%
Cancer
28%
Mitogen-Activated Protein Kinase
28%
Signal Transduction Pathway
14%
Overall Survival
14%
Oncogene
14%
Metastatic Melanoma
14%
Molecularly Targeted Therapy
14%